Two recent studies have suggested that a schizophrenia susceptibility locus may lie on the proximal long arm of chromosome 5. Partial trisomy of a 20-30 centimorgan region of chromosome 5 (5qll.2-13.3) was found to cosegregate with schizophrenia in a Canadian family of Chinese descent. Moreover, DNA markers from proximal 5q (D5S39, D5S76) were found to be linked to schizophrenia and related disorders in seven British and Icelandic families. We now report an initial physical map of DNA markers relative to the partial trisomy chromosome 5, as well as preliminary evidence against linkage of this region to schizophrenia in four American families.
Students of schizophrenia have long recognized a genetic contribution to this common disorder. Bleuler (1911) himself suggested that the relatives of patients were often "tainted by hereditary mental disease." Over the ensuing decades, family, twin, and adoption studies have supported this notion.
More than 20 studies of the relatives of more than 5,000 affected individuals have consistently revealed elevated morbid risks for schizophrenia among the firstdegree relatives of patients with the disorder, suggesting that schizophrenia is familial (Gottesman and Shields 1982) . Of interest, other disorders (schizoaffective disorder, paranoid disorder, schizotypal personality disorder) as well as eyetracking dysfunctions (Holzman et al. 1988 ) also aggregate in the relatives of schizophrenic patients: such "variable expression" has given rise to the concept of a schizophrenia spectrum (Kendler et al. 1985) .
Similarly, studies of almost 1,000 monozygotic (MZ) and same-sex dizygotic (DZ) twin pairs have demonstrated an almost fourfold greater probandwise concordance for schizophrenia among the former than the latter, suggesting that schizophrenia is not only familial, but generic (Kendler 1986) . It is worth noting, however, that about one-half of MZ twin pairs are discordant for schizophrenia despite generic identity. This may either indicate that schizophrenia is etiologically heterogeneous, with genetic forms affecting both members of some twin pairs and environmental forms affecting individual members of others, or that schizophrenia is typified by "reduced penetrance" (i.e., that additional environmental factors are necessary for the final expression of even genetic forms of the disorder). The finding that the offspring of nonschizophrenic cotwins in discordant MZ twin pairs are at the same elevated risk for the disorder as the offspring of schizophrenic cotwins implies that reduced penetrance contributes to at least some of the discordance among MZ twins (Fischer 1971; I.I. Gottesman, personal communication) .
Finally, adoption studies (adoptee study method, adoptee's family method, cross-fostering method, and study of MZ twins reared apart) have consistently suggested a role for genetic factors in schizophrenia (reviewed in Rieder and Kaufmann 1988 . It would appear that under some conditions (such as recessive or intermediate disorders with low heterozygote penetrance), segregation analysis may be relatively insensitive to major loci (Goldin et al. 1984) . In such situations, however, other statistical genetic methods such as linkage analysis may detect and localize important disease genes.
Schizophrenia falls under the category of "complex" genetic disorders which can be characterized by relatively high prevalence, variable expression, etiological heterogeneity, and incomplete penetrance. Traditionally, such disorders have not readily yielded to genetic linkage analysis. Recent advances, including the availability of a complete restriction fragment length polymorphism (RFLP) linkage map of the human genome, have paved the way for applying linkage analysis to these disorders (Lander and Botstein 1986 ). Yet, even if plausible, such analyses are no less complex than the disorders they purport to evaluate. With well over 1,200 RFLP markers having been identified which span the 3 billion base pairs (bp) of DNA (3,300 centimorgans [cM]) contained in the human genome (Human Gene Mapping 9, 1987) , it is by no means obvious where to begin the search for a single major locus in schizophrenia.
A strategy that has successfully directed the search for a number of disease genes has been to identify cytogenetic abnormalities associated with the disease. Thus, chromosomal translocations and deletions have ultimately led to cloning the oncogenes involved in Burkitt's lymphoma, chronic myeloid leukemia, and retinoblastoma . Furthermore, other chromosomal changes have provided important leads for genetic linkage analyses of two neuropsychiatric disorders: Duchenne's muscular dystrophy and familial Alzheimer's disease.
Duchenne's Muscular Dystrophy
The recognition of chromosomal abnormalities associated with Duchenne's muscular dystrophy was of critical importance in the initial localization of the gene for that disease. The existence of rare affected female patients with balanced X-autosome translocations, each with break points at the band Xp21 (Boyd and Buckle 1986), as well as several male patients with interstitial deletions of Xp21 , suggested that the gene for the disorder might lie in this chromosomal region. Tight linkage between Duchenne's muscular dystrophy and cloned DNA segments that physically mapped close to Xp21 lent additional support to a disease locus in this band (Davies et al. 1983; .
Familial Alzheimer's Disease
The presence of a chromosomal anomaly likewise suggested a possible location for the gene underlying autosomal dominant Alzheimer's disease. Patients with Down's syndrome (trisomy 21) reaching their fifth decade frequently develop neuropathological changes (senile plaques, neurofibrillary tangles) that are characteristic of Alzheimer's disease (Davies 1986 ). This clue led Gusella and associates to generate RFLP markers for chromosome 21 from a flow-sorted chromosomespecific DNA library; to construct a linkage map of chromosome 21 by tracing the segregation of 12 of these markers in portions of the Venezuelan Huntington's disease pedigree (Tanzi et al., in press); and ultimately, to establish linkage between two markers in region 21q21 (D21S1/D21S11; D21S16) and Alzheimer's disease in four large kindreds with histologically proven disease (St. George-Hyslop et al. 1987) .
Chromosomal Abnormalities and Schizophrenia
Similarly, the identification of karyotypic abnormalities associated with schizophrenia might provide important leads in the search for the chromosomal location of major genes in this disorder (Gurling 1986) . In fact, since 1962 a variety of cytogenetic anomalies have been described in schizophrenia (reviewed in DeLisi et al. 1988 the situation with female cases of Duchenne's muscular dystrophy, cited earlier). Perhaps more critical is that such cases have not always suffered from schizophrenia as currently defined, but from other psychotic conditions, often complicating mental retardation. Moreover, they have frequently occurred in isolation, suggesting a coincidental rather than a causal role for the chromosomal abnormality in the patient's (relatively common) psychiatric disorder.
It was for these reasons that the report of also see Bassett 1989) was greeted with such enthusiasm. The nephew/ uncle pair described therein both met DSM-IU-R (American Psychiatric Association 1987) criteria for schizophrenia. In addition, their illnesses were characteristic in other respects: they occurred in the absence of frank mental retardation, were responsive to neuroleptic treatment, and were associated with other features frequently found in schizophrenic patients, namely, smooth pursuit eye movement abnormalities (Iacono et al. 1988 ). The ill individuals, both of whom demonstrated a partial trisomy of the chromosome 5 segment 5qll.2-5ql3.3 on high-resolution banding (karyotype: 46,XY, der(l) inv ins 1,5 q32.2; ql3.3qll.2), appeared to be uniquely affected. Other family members, including their mother/ sister (demonstrating a balanced translocation: 46,XX, inv ins 1,5 q32.2; ql3.3qll.2 ?mat?pat) were diagnostically and otherwise phenotypically normal. The odds that the chromosomal anomalies, schizophrenia, and eye movement dysfunctions occurred together by chance in the eight individuals studied by Bassett et al. may be calculated, assuming that chromosomal anomalies occur in 0.5 percent of living newborns (Vogel and Motulsky 1986, p. 79) , by adopting the Mendelian latent structure model and parameter estimates of Holzman et al. (1988, p. 644) . The likelihood ratio (LR) one obtains is 14.0 in favor of a causal over a coincidental association, corresponding to a "strong level of support" (S = ln[LR]) of 2.64 (Edwards 1972 ) (calculation available from C.A. Kaufmann on request).
These results strongly suggested an association between the chromosomal anomalies and schizophrenia in this family. They further suggested, but did not ensure, that a major gene for schizophrenia lay within the trisomic region of chromosome 5. An alternative explanation might be that the partial trisomy chromosome 5 acts in trans, affecting some critical metabolic pathway encoded on a different chromosome; the finding that trisomy 21 is associated with increased activity of the X-linked enzyme, glucose-6-phosphate dehydrogenase, raises the possibility of such a mechanism (Vogel and Motulsky 1986, p. 327) . Nonetheless, they defined a candidate region in which to begin the search for genetic markers linked to a schizophrenia locus.
Physical Mapping of Chromosome 5q
Using a strategy similar to that described previously for Duchenne's muscular dystrophy and familial Alzheimer's disease, we undertook to identify DNA markers that derived from the partial trisomy region. We intended, in turn, to use these markers in a linkage analysis of schizophrenia pedigrees. To assign markers to the trisomic region, we made use of human: rodent somatic cell hybridization. Since its introduction in 1967, this approach has served as a major means for the chromosomal assignment of genes and anonymous DNA markers (Bruns 1989) . It entails fusing hamster and human cells with polyethylene glycol, growing the resulting heterokaryons under selective pressure, and passaging the hybrids to promote the preferential loss of human chromosomes, and it results in cells that contain several hamster, but only one human, chromosome.
Chinese hamster ovary cells, deficient for three genes encoded on human chromosome 5q, were fused with lymphoblastoid cells from the balanced translocation carrier in the family described by . Several rounds of cell division under selective pressure produced a hybrid cell line (HHW1064) retaining as its only human complement chromosome 5 deleted for the trisomic region. DNA from this cell line, as well as from a matched cell line retaining a normal human chromosome 5 (HHW105), was digested with restriction endonucleases, separated electrophoretically, transferred to nylon membranes, and hybridized to a series of radiolabeled DNA markers from the centromeric and long-arm portions of chromosome 5 (Gilliam et al., submitted for publication).
This "deletion mapping panel" indicated the following physical map positions (figure 1): outside of (and, on the basis of genetic mapping, centromeric to) the trisomic region-JOllOHc (D5S21) and L599Ha (D5S76); within the trisomic region-LM4 (D5S6), 105-153Ra P5S39), and 105-798Rb (D5S78). These physical map locations have been corroborated by genetic mapping, with LM4 lying approximately midway between L599Ha and 105-153Ra and the following intermarker male recombination fractions: JOllOHc to L599Ha-13 cM; L599Ha to LM4-7 cM; LM4 to 105-153Ra-6 cM; 105-153Ra to 105-798Rb-8 cM (Leppert et al. 1987 ; L. Giuffra and J. Kennedy, personal communication). On the basis of these preliminary results, we estimate the trisomic region to make up at least 20-30 cM (male generic length), or about 30 percent of 5q (1 percent of the human genome) (Ott 1985, p. 11) . Conceivably, such a region might contain over 500 genes.
Linkage Analysis of a Susceptibility Locus for Schizophrenia on Chromosome 5q
Having identified several DNA markers lying in or near the trisomy region, we embarked on a linkage analysis of multigenerational families segregating schizophrenia.
Pedigrees. Four large North American families, each containing two siblings with chronic schizophrenia, were recruited by advertisement through the National Alliance for the Mentally 111 and chosen for initial study because of their informativeness for linkage analysis (P0765, P1250, P1257, P1274) (DeLisi et al. 1987) . Several members from each family were interviewed with a structured family interview schedule to obtain a complete family history and clinical information on all ill family members. A total of 48 individuals from these families had blood samples taken and were interviewed by one of three experienced psychiatrist or social worker interviewers using the Schedule for Affective Disorder and Schizo- 
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Depicted on the left of the figure are the physical map locations of the five DNA markers described In the text relative to the schizophrenia-associated region 5q11.2-5q13.3. Shown on the right of the figure are the genetic linkage distances between the same markers. Numbers given refer to female (leftmost) and male (rightmost) recombination fractions Genetic data are from (Leppert et al. 1987) and Giuffra, L. and Kennedy, J., personal communication. 1978) . In addition to the interviews, medical records were obtained from all inpatients and outpatients undergoing psychiatric treatment. Family interviews, SADS-L results, medical records, and any other collateral information were then collated by two independent, experienced psychiatrist-diagnosticians without knowledge of familial relationships, and a best-estimate diagnosis (RDC and DSM-111-R) was determined.
phrenia-Lifetime Version (SADS-
Seventeen individuals among the four families met RDC and DSM-111-R criteria for chronic schizophrenia or schizoaffective disorder ( figure 2 ). An additional five individuals were diagnosed as suffering from schizorypal, schizoid, or paranoid personality disorder. Thirteen other family members suffered from a variety of illnesses, including bipolar, major and minor depressive, generalized anxiety, and panic disorders.
Simulations. To assess the power of the three largest of these four families to detect (or, for that matter, to exclude) linkage to the trisomy region, computer simulations were undertaken with the program GENRiSK (Sandkuyl and Ott, in press). As suggested by Boehnke (1986), these simulations were performed subsequent to diagnostic assessment but before obtaining marker information. Power calculations were based on the following assumptions and parameter estimates: autosomal dominant mode of inheritance; disease gene frequency (q) 0.01; disease penerrance vector in the last generation (i.e., in individuals with no children) (where dd corresponds to the phenocopy rate, i.e., the rate of illness in homozygous normal individuals, and dD and DD correspond to the rate of illness in heterozygous and homozygous affected individuals, respectively); two allele codominant markers with allele frequencies Al = 0.5 and A2 = 0.5 located 5 cM from the disease locus. Five hundred replicates of the three pedigrees were generated, and linkage between the disease and marker loci was tested with a modified version of the program LIPED (Ott 1974) . Overall, the three pedigrees, comprising 39 individuals, 14 of whom suffered from chronic schizophrenia or schizoaffective disorder, demonstrated an average lod score of 1.03. Moreover, 11 percent of the replicates revealed a lod score > 2 and 2 percent, a lod score > 3. On the basis of these simulations, we concluded that the pedigrees chosen for study afforded modest power to detect linkage between a schizophrenia locus and an individual marker locus. We further speculated that "interval mapping"-that is, a search for linkage between the disease locus and an interval defined by several closely spaced marker loci-would offer significantly more power to detect, and to an even greater extent, exclude linkage (Lander and Botstein 1986).
Marker Typing. For this reason, 42 members of the four families providing blood samples were typed for the 5 linked RFLP markers described above. All marker typing was performed without knowledge of diagnostic information. Lymphoblastoid cell lines were established by the method of Anderson and Gusella (1984) . DNA was digested with appropriate restriction endonucleases, separated electrophoretically, and transferred to nylon membranes by established procedures (Gilliam et al. 1987) . Following excision of insert fragments from low-melt agarose, probes were radiolabeled by oligonucleoride priming (Feinberg and Vogelstein 1984) . Probe JOllOHc (locus D5S21) detects an Mspl polymorphism with alleles 8.7 kb and 7.2 kb (with allele frequencies of 0.56 and 0.44); L599Ha (D5S76) (following preincubation with sonicated human placental DNA to reduce hybridization to repeat DNA elements [Sealy et al. 1985] ) detects a TaqI polymorphism with alleles 17.0 kb, 14.0 kb, and 10.0 kb (0.32, 0.16, 0.52); LM4 (D5S6) detects a BamHI polymorphism with alleles 11.0 kb, 9.6 kb, and 7.6 kb (0.33, 0.52, 0.15); 105-153Ra (D5S39) detects an Mspl polymorphism with alleles 8.0 kb and 5.0 kb (0.40, 0.60); and 105-798Rb (D5S78) detects an Mspl polymorphism with alleles 2.3 kb and 1.8 kb (0.57, 0.43). Genotypes for these five markers in all typed individuals are listed in table 1.
Linkage Analysis. As a complex disorder, schizophrenia is characterized by certain features, such as 
'Subject numbers correspond to those appeanng in figure 2. Numbers beneath each probe correspond to the following alletes: J01 1-8 7 kb, 2-7.2 kb; 599 1-17 0 kb, 2-14 0 kb, 3-10.0 kb; LM4 1-11.0 kb, 2-9 6 kb, 3-7 6 kb; 153 1-8.0 kb, 2-5.0 kb; 798 1-2 3 kb, 2-1.8 kb Genotypes of "00" Indicate that a partcular probe was not in that individual.
incomplete penetrance and variable expression, that complicate linkage analysis (Lander and Botstein 1986; also see discussion to follow). We initially decided to adopt a diagnostically conservative, albeit statistically less powerful approach, considering as "affected" only those individuals with either chronic schizophrenia or schizoaffective disorder and considering as "phenotype unknown" all other individuals. We conducted pairwise and multipoint analyses between disease, so defined, and the five chromosome 5q markers described earlier. Other parameters of the analyses include autosomal dominant model of inheritance phenocopy rate 0.001, and gene frequency 0.0085. Pairwise analyses were conducted with the program MLINK (Lathrop et al. 1985 ) (ignoring sex differences in recombination fraction); multipoint analyses were performed with the program LINK-MAP (Lathrop et al. 1985) , setting the female:male recombination ratio, at 1.5 throughout the region studied. Table 2 shows the results of pairwise analyses. Data shown are the sum of the lod scores obtained for each of the four pedigrees. Negative lod scores were obtained for loci D5S21, D5S6, and D5S39, reaching a minimum at 0.00 recombination for D5S6. Despite limited statistical power, significant support for exclusion of linkage at this recombination fraction was obtained (lod score < -2).
As shown in figure 3, two contiguous 4-point linkage analyses (schizophrenia vs. D5S21-D5S76-D5S6 and D5S6-D5S39-D5S78, respectively) provided evidence against linkage throughout the region examined, reaching a statistically significant minima (lod score < -2.5) at D5S6.
Discussion
We have described two complementary approaches, physical and genetic mapping, which hold the promise of uncovering major genes in schizophrenia. These approaches are useful in demonstrating genetic abnormalities at a level of resolution of IO 7 to 10 s bp (10 to 10° cM) and 106 to IO 7 bp (1 to 10 cM), respectively. As such, they provide resolution at a more microscopic Shown are the results of two 4-point linkage analyses between schizophrenia and the schizophreniaassociated region of chromosome 5: the first moves the schizophrenia locus across a fixed map of J01 (D5S21)-599 (D5S76H-M4 (D5S6); the second moves the locus across a fixed map of LM4 (D5S6M53 (D5S39)-798 (D5S78) D5S21 was arbitrarily set at 0 00 M D5S76, D5S6, D5S39, and D5S78 were set at 0.13 M, 0.20 M, 0 26 M, and 0 34 M, respectively (male distances; female/male ratio throughout the region 1 5) level than traditional methods like karyotyping (10 8 bp) and at a more macroscopic level than newer methods like held inversion and pulse field gel electrophoresis (10 4 to 10 7 bp) (Poustka and Lehrach 1986; Lupski and Caskey 1989) . Our ultimate aim is to uncover abnormalities in single genes, on the order of 10 3 bp. The physical map of chromosome 5q that we have developed is rudimentary and incomplete. Nonetheless, it provides several leads in our search for major genes in schizophrenia:
1. It allows the recent report of Sherrington et al. (1988) of a schizophrenia susceptibility locus on chromosome 5, identified through genetic linkage, to be compared to the report of of a schizophrenia-associated cytogenetic abnormality on chromosome 5, identified through high-resolution banding. One of the ) appears to lie within the Bassett trisomy region, while the second probe (L599Ha [D5S76]) lies just outside and proximal to the region. These results suggest that the map positions for a schizophrenia locus derived from these two approaches are consistent with each other.
2. It suggests additional DNA probes that might be evaluated in the Icelandic and British pedigrees studied by Sherrington and associates. We would predict that the probe LM4 (D5S6), lying between the two aforementioned linked probes, would also be linked to the putative schizophrenia locus.
3. It provides a means to localize other markers believed by genetic mapping or in situ hybridization to be derived from the proximal long arm of chromosome 5. For example, it might allow more precise localization of the dihydrofolate reductase gene, the position of which has heretofore remained uncertain.
4. Not only could it be used to screen known markers for their location, but it could be used in screening novel polymorphic clones derived from flow-sorted chromosome 5 libraries (Gilliam et al. 1987) .
5. It may be used to enrich for clones derived from the trisomy region, through an approach, known as (fPERT) subtractive hybridization, that was successfully used in the isolation of the Duchenne muscular dystrophy gene . Flow-sorted library screening and subtractive hybridization experiments are currently underway in our laboratory.
6. These (we anticipate over 30) new polymorphic clones in combination with the approximately 10 recognized polymorphisms in or near the trisomic region should permit a genetic map at 1-2 cM resolution in large reference pedigrees. Employing these new markers in linkage studies with chromosome 5 linked schizophrenia pedigrees may, in turn, permit the identification of closer probes flanking the susceptibility locus, assuming that an adequate number of recombinants can be found. This would allow an "obligate" chromosomal region (OCR) that must contain the susceptibility locus to be defined, as a prelude to subsequent fine physical mapping and cloning of the entire region (Smith and Cantor 1986) .
7. Assuming we successfully define a small OCR of 1-2 Mb, the panel of densely spaced markers from the susceptibility region may allow for the recognition in some patients of "micro-deletions" that had previously escaped detection because of their small size. Cloned DNA sequences corresponding to the genetic material missing in the smallest deletions might then serve as probes for studying cDNA libraries from brain regions thought to express the disease gene .
Turning now to our linkage results, we find several aspects worthy of comment:
1. We, like Kennedy et al. (1988) and unlike Sherrington et al. (1988) , have preliminary evidence to exclude a susceptibility locus for schizophrenia from chromosome 5q. There are two possible explanations for these divergent findings. As previously mentioned, schizophrenia is a common, complex disease and may very well demonstrate (nonallelic) generic heterogeneity. Similarly divergent results have been obtained with familial Alzheimer's disease and bipolar disorder, where chromosome 21 linked and unlinked, and chromosome 11, X chromosome, and non-11/non-X forms have been respectively recognized (Baron et al. 1987; DeteraWadleigh et al. 1987; Egeland et al. 1987; St. George-Hyslop et al. 1987; Schellenberg et al. 1988 ).
The alternative explanation, if true, would be somewhat more sobering. Given the uncertainties inherent in analyzing disorders with variable expression and incomplete penetrance, Sherrington et al. (1988) were led to test for linkage under various assignments of affection status and estimates of disease penetrance. Yet the effects of conducting multiple analyses are unclear. We are currently using the computer simulation approach described herein to assess the type I error rate implicit in such analyses. It should be noted that the analytic scheme adopted by Sherrington and associates which comes closest to ours is their "penetrance free" (PF) model. Under this model, they achieved a suggestive, but inconclusive, multipoint lod score of 2.45 (Sherrington et al. 1988, p. 166) . We have already suggested that one way to test for specious linkage would be to examine a marker, like LM4, which lies between the two markers linked to the schizophrenia locus.
2. Our results demonstrate the power of interval mapping in excluding (or detecting) linkage. Despite relatively small pedigrees with limited power, we were able to exclude a schizophrenia locus in the vicinity of LM4, under an assumption of monogenic inheritance. Lander and Botstein (1986) estimate that interval mapping reduces by more than 50 percent the number of informative meiotic events needed to exclude linkage and, to a lesser extent, the number of events one must score to establish linkage.
3. Despite interval mapping, the region we were able to exclude, while critical, is quite narrow. It would appear that we sacrificed considerable power in order to reduce the chance of spurious linkage. Clearly, alternative approaches to linkage analysis, which do not make assumptions about the mode of disease inheritance or about the extent of disease penetrance, would be welcome. Derivatives of the affected sib-pair approach (Suarez et al. 1978 ) that afford greater statistical power have been developed. These include the affected-pedigreemember method (Weeks and Lange 1988) and the "extended" sib-pair method (Sandkuyl, submitted for publication) and might profitably be applied to studies of schizophrenia.
In conclusion, we have developed a preliminary physical map of a region of chromosome 5 associated with schizophrenia. While linkage analysis does not suggest a susceptibility locus for schizophrenia within this region in the four pedigTees we studied, it does demonstrate the power of this approach to detect or exclude major genes.
